CorWave

About CorWave

CorWave is a clinical-stage medical device company focused on developing innovative heart-assist pumps to address heart failure, a major public health challenge. Their mission is to expand the use of cardiac assist devices and provide reliable, sustainable, and physiological solutions to improve patients' quality of life.

Products & Services

Wave Membrane:A disruptive technology in cardiac support that ensures truly pulsatile blood flow.

CorWave LVAS:A Left Ventricular Assist Device (LVAD), an implantable heart assist pump for treating advanced heart failure. Currently an investigational device, not approved for commercial use.

Nemo:A heart-assist pump product under development, specific details not provided in the content.

Specialties

Heart-assist pumps Cardiac support technology Left Ventricular Assist Devices (LVADs) Solutions for advanced heart failure

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 66490000 MR: - FA: 61 million euros FAN: 66490000	D: 2023-06-20 FD: 2023-06-20	4 investors

Series C Latest

2023-06-20

$66.5M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jean-Baptiste Drevet

Engineer, researcher, and passionate inventor

G

Gérard Hascoët

Chairman of the Board of CorWave

T

Tim Lenihan

P

Philippe Boucheron

Investment Director

W

Wen Wen Cheng

Head of Legal at Ysios Capital

E

Emmanuelle Coutanceau

Partner

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

CorWave Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised